Related Experiment Video
Updated: Jan 20, 2026

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
Published on: August 15, 2020
A concise review of human brain methylome during aging and neurodegenerative diseases
1Department of Life Science, University of Seoul, Seoul 02504, Korea.
Abstract:
DNA methylation at CpG sites is an essential epigenetic mark that regulates gene expression during mammalian development and diseases. Methylome refers to the entire set of methylation modifications present in the whole genome. Over the last several years, an increasing number of reports on brain DNA methylome reported the association between aberrant methylation and the abnormalities in the expression of critical genes known to have critical roles during aging and neurodegenerative diseases. Consequently, the role of methylation in understanding neurodegenerative diseases has been under focus. This review outlines the current knowledge of the human brain DNA methylomes during aging and neurodegenerative diseases. We describe the differentially methylated genes from fetal stage to old age and their biological functions. Additionally, we summarize the key aspects and methylated genes identified from brain methylome studies on neurodegenerative diseases. The brain methylome studies could provide a basis for studying the functional aspects of neurodegenerative diseases. [BMB Reports 2019; 52(10): 577-588].
Related Concept Videos
07:04Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
09:36Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
19:50Interview: Protein Folding and Studies of Neurodegenerative Diseases
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
07:27Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:22Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease

